Changes to Psychopharm/Pediatric Panel Meeting Notice
08/23/2004
Federal Register Notice: FDA is amending the notice of the joint meeting of the 9/13-14 Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee to reflect changes in the Addresses and Procedure portions of the document. To view this notice, click here.
